SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0000950142-22-002306
Filing Date
2022-07-25
Accepted
2022-07-25 17:17:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM 424B7 eh220273678_424b7-201.htm 424B7 5439
  Complete submission text file 0000950142-22-002306.txt   6540
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-264201 | Film No.: 221104293
SIC: 2834 Pharmaceutical Preparations